2010 EDD domain
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 5 | 12.1 | 0.41× | q = 9.3e-3 | |
| Homogeneous non-metal compounds | 2 | 5.3 | 0.38× | q = 0.20 | |
| Nucleosides, nucleotides, and analogues | 2 | 6.8 | 0.29× | q = 0.06 | |
| Lipids and lipid-like molecules | 18 | 2.7 | 6.56× | not tested | |
| Organic oxygen compounds | 6 | 4.9 | 1.22× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03796 | PLM | Palmitic Acid | 22 |
| DB08231 | MYR | Myristic acid | 7 |
| DB01775 | 2HA | Dihydroxyacetone | 6 |
| DB04801 | VCA | cis-Vaccenic acid | 4 |
| DB16833 | ADP | Adenosine disphosphate | 3 |
| DB02263 | G3H | D-glyceraldehyde 3-phosphate | 2 |
| DB02580 | PG6 | Pentaglyme | 2 |
| DB03193 | STE | Stearic acid | 2 |
| DB03756 | HXA | Doconexent | 2 |
| DB14104 | EIC | Linoleic acid | 2 |
| DB04224 | ELA | Oleic Acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| PLM | PALMITIC ACID | 22 |
| NAmetal | SODIUM ION | 8 |
| MYR | MYRISTIC ACID | 7 |
| 2HA | Dihydroxyacetone | 6 |
| CAmetal | CALCIUM ION | 6 |
| OLA | OLEIC ACID | 4 |
| VCA | VACCENIC ACID | 4 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 3 |
| ZNmetal | ZINC ION | 3 |
| 15P | POLYETHYLENE GLYCOL (N=34) | 2 |
| BMJ | (12R)-12-methyltetradecanoic acid | 2 |
| BNV | (12S)-12-methyltetradecanoic acid | 2 |
| D0G | (14S)-14-methylhexadecanoic acid | 2 |
| EIC | LINOLEIC ACID | 2 |
| G3H | GLYCERALDEHYDE-3-PHOSPHATE | 2 |
| HXA | DOCOSA-4,7,10,13,16,19-HEXAENOIC ACID | 2 |
| PG6 | 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE | 2 |
| STE | STEARIC ACID | 2 |
| BR | BROMIDE ION | 1 |
| CL | CHLORIDE ION | 1 |